Greenlight Biosciences Inc.
Other Technology · Medford, Massachusetts
Greenlight Biosciences Inc. is a other technology company based in Medford, Massachusetts. It has raised at least $196.4 million across 5 known rounds, of which $171.3 million was reported to the SEC on 4 Form D filings, most recently in 2020.
| Date | Round | Amount | Raised to date | Lead investor | Source |
|---|---|---|---|---|---|
| 2020-06-26 | — | $102.5M | $196.4M | SEC Form D | |
| 2020-05-12 | — | $17.0M | $93.8M | Round pagesource ↗ | |
| 2018-12-19 | — | $38.7M | $76.8M | SEC Form D | |
| 2017-09-14 | — | $10.0M | $38.1M | SEC Form D | |
| 2015-06-16 | — | $20.0M | $28.1M | SEC Form D | |
| 2013-08-09 | —+1 amd | $8.0M | $8.0M | SEC Form D |
SEC rows are Form D filings, where the amount is what was actually sold and amendments update a round rather than adding one. Press rows are split between company-issued releases or wires and editorial or third-party coverage. The total is therefore a floor: a round nobody reported is a round we cannot see. A buyout or control change appears in the timeline but is never added to the total: that money goes to shareholders, not into the company.
Form D is the notice a company files with the SEC when it sells securities without registering them. It reports the amount sold, not a valuation. Figures here are what the filing says. Where a filing is silent, the field is left blank rather than estimated. “Total raised” adds press-reported rounds that never appear in a filing, so it is a floor rather than an audited sum: press amounts are the figures the company announced, and a round nobody reported is a round we cannot see.